Malignant Bladder Neoplasm — Trials

Malignant Bladder Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,511 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 346
Recruiting: 177
Ph III recruiting: 23
Growth YoY: +19.4%
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 31.2%
Trials / 1,000 deaths: 20 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (179)

clinicaltrialsPublishedShowing 151–200 of 472 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05531123	Risk-stratification Based Bladder-sparing Modalities for Muscle-invasive Bladder Cancer	active not recruiting	Phase 2	30	Fudan UniversityOTHER	1	Jul 20, 2026	clinicaltrials
NCT05833867	Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer	recruiting	Phase 1	20	Shilpa Gupta, MDOTHER	1	Jul 20, 2026	clinicaltrials